Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stanford-Lucidify EEG Delirium Study
Sponsor: Stanford University
Summary
The purpose of this study is to evaluate the effectiveness of the CGX/Lucidify EEG system in enabling physicians to detect delirium (confusion) in medically ill patients as early as possible in order to minimize the detrimental effects of delirium. The study will involve collecting EEG data through the CGX EEG system (a Research-grade 2-Channel EEG device) and applying the Lucidify EEG software algorithm to identify indicators and degree of delirium, obtain data regarding the amount and degree of patient's movement and activity throughout the day in order to detail delirium subtype, and obtain data regarding the quality of the sleep as it affects delirium severity and duration. By enhancing early detection, this research aims to improve patient outcomes and inform clinical decision-making.
Official title: Stanford-Lucidify Delirium Monitoring Pilot Study
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2025-06-01
Completion Date
2026-05-30
Last Updated
2025-05-31
Healthy Volunteers
No
Conditions
Interventions
Electroencephalogram (EEG)
All study subjects will undergo monitoring via a portable electroencephalogram (pEEG), the CGX EEG system (a Research-grade 2-Channel EEG device) to measure the brainwaves of patients admitted to Stanford Medical Center. Investigators will then use the Lucidify software to allow for the interpretation of obtained brainwaves for the detection of delirium .
Locations (1)
Stanford Hospital and Clinics
Stanford, California, United States